Browse Drug Recalls
1,198 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,198 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,198 FDA drug recalls in 2016.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Dec 29, 2016 | Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : ... | Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of p... | Class III | Hetero Drugs Ltd. - Unit 1 |
| Dec 28, 2016 | Flucanozole Tablets, USP, 200 mg, a) 30 count (NDC 55111-146-30) and b) 100 c... | Failed Dissolution Specifications; 18 month stability time point | Class II | Dr. Reddy's Laboratories, Inc. |
| Dec 28, 2016 | Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only,... | Microbial Contamination of Non-Sterile Product; small number of tubes may include the presence of... | Class II | L. Perrigo Company |
| Dec 28, 2016 | Flucanozole Tablets, USP, 100 mg, a) 30 count (NDC 55111-144-30) and b) 100 c... | Failed Dissolution Specifications; 18 month stability time point | Class II | Dr. Reddy's Laboratories, Inc. |
| Dec 28, 2016 | Flucanozole Tablets, USP, 50 mg, a) 30 count (NDC 55111-143-30) and b) 100 co... | Failed Dissolution Specifications; 18 month stability time point | Class II | Dr. Reddy's Laboratories, Inc. |
| Dec 28, 2016 | Flucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. R... | Failed Dissolution Specifications; 18 month stability time point | Class II | Dr. Reddy's Laboratories, Inc. |
| Dec 27, 2016 | Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by ... | Superpotent Drug; out of specification results for assay (manufacturer) | Class III | The Harvard Drug Group |
| Dec 22, 2016 | Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratori... | Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint. | Class II | Roxane Laboratories, Inc. |
| Dec 22, 2016 | TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for:... | Failed Stability Specifications | Class III | Vintage Pharmaceuticals LLC, DBA Qualitest Phar... |
| Dec 22, 2016 | Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactu... | Failed dissolution specification: recalled due to an out of specification dissolution result of 4... | Class II | Sandoz Incorporated |
| Dec 22, 2016 | Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottle... | Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted caps... | Class II | Aurobindo Pharma USA Inc |
| Dec 21, 2016 | Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bo... | Subpotency: due to a low, out of specification test result for assay during stability testing. | Class II | Teva Pharmaceuticals USA |
| Dec 20, 2016 | Temozolomide Capsules, 140 mg, packaged in a) 5-count bottles (NDC 0378-5263-... | Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resultin... | Class II | Mylan LLC. |
| Dec 20, 2016 | Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-... | Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resultin... | Class II | Mylan LLC. |
| Dec 20, 2016 | buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count ... | Failed Dissolution Specifications; 18 month stability time point | Class III | Sun Pharmaceutical Industries, Inc. |
| Dec 20, 2016 | Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord... | Failed tablet/capsule specification: missing break line on the 5mg tablet. | Class II | Accord Healthcare, Inc. |
| Dec 20, 2016 | buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (ND... | Failed Dissolution Specifications; 18 month stability time point | Class III | Sun Pharmaceutical Industries, Inc. |
| Dec 20, 2016 | Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceutical... | Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resultin... | Class II | Mylan LLC. |
| Dec 20, 2016 | Temozolomide Capsules, 100 mg, packaged in a) 5-count bottles (NDC 0378-5262-... | Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resultin... | Class II | Mylan LLC. |
| Dec 19, 2016 | Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex... | Superpotent Drug: Product may not meet specifications throughout shelf life. | Class III | Apotex Inc. |
| Dec 16, 2016 | MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per c... | Failed Impurities/Degradation Specifications | Class II | Fresenius Kabi USA, LLC |
| Dec 16, 2016 | Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only,... | Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance. | Class III | Aurobindo Pharma USA Inc |
| Dec 15, 2016 | Phenylephrine 2.5% + Tropicamide 1% Compounded Eye Drops Solution, 5 mL bot... | Lack of Sterility Assurance | Class II | Meta Pharmacy Services |
| Dec 15, 2016 | Gentell Hydrogel Ag Saturated Gauze, 2"x2"(NDC 61551-112-20), 4x4(NDC 61554-... | CGMP Deviations | Class II | Gentell, Inc |
| Dec 15, 2016 | Gentell Hydrogel Wound Dressing REGULAR, 4 oz. tube, Manufactured by: Gentell... | CGMP Deviations | Class II | Gentell, Inc |
| Dec 15, 2016 | AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused p... | Lack of Assurance of Sterility: Potential cracks in glass vials | Class II | Amgen, Inc. |
| Dec 14, 2016 | Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spra... | Defective Delivery System: out of specification result for droplet size distribution at the d90 m... | Class III | Roxane Laboratories, Inc. |
| Dec 14, 2016 | Torsemide Tablets, 20 mg 100-count bottle, Rx only, Manufactured by: Apotex I... | CGMP Deviations | Class II | Apotex Corp. |
| Dec 14, 2016 | Torsemide Tablets, 5 mg 100-count bottle, Rx only ,Manufactured by: Apotex In... | CGMP Deviations | Class II | Apotex Corp. |
| Dec 13, 2016 | Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC ... | Subpotent Drug: out of specification results for assay test. | Class III | Sandoz Inc |
| Dec 13, 2016 | Nano PNC Water, packaged in amber glass bottles, Rx only, ICRPstudy.com, Immu... | Marketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled... | Class I | Pacific Medical Solutions |
| Dec 12, 2016 | VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic... | cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert. | Class III | VIRTUS PHARMACEUTICALS OPCO II L |
| Dec 12, 2016 | Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing ... | cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert. | Class III | VIRTUS PHARMACEUTICALS OPCO II L |
| Dec 12, 2016 | Extra-Virt Plus DHA Prenatal/Postnatal Softgel, Prescription Multivitamin/Min... | cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert. | Class III | VIRTUS PHARMACEUTICALS OPCO II L |
| Dec 12, 2016 | Virt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Di... | cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert. | Class III | VIRTUS PHARMACEUTICALS OPCO II L |
| Dec 12, 2016 | Rabeprazole Sodium Delayed Release Tablets, 20 mg, a) 30-count bottle (NDC 65... | Failed Dissolution Specifications | Class II | Amneal Pharmaceuticals LLC |
| Dec 9, 2016 | SLIMFIT X capsules, packaged in a 60-cont bottle | Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibut... | Class I | Jersey Shore Supplements, LLC |
| Dec 7, 2016 | Novacort Gel Sample Packets (2% hydrocortisone acetate, 1% pramoxine HCl), 10... | Subpotent Drug: Out of specification result for pramoxine hydrochloride | Class III | Novum Pharma, LLC |
| Dec 6, 2016 | INOVA (benzoyl peroxide) 4%, Easy Pad (tocopherol) 5%, For topical use only,... | Subpotent Drug: Product label claim is 4% Benzoyl Peroxide, Initial Stability testing showed vari... | Class III | Cipher Pharmaceuticals US LLC |
| Dec 6, 2016 | Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intrav... | Lack of Assurance of Sterility: confirmed customer complaints of leaking bags. | Class II | Baxter Healthcare Corporation |
| Dec 6, 2016 | 10% Premasol sulfite-free (Amino Acid) Injection, 2000 mL bulk package, Rx on... | Discoloration: there were customer reports of yellow discolored solution. The yellow coloration i... | Class II | Baxter Healthcare Corporation |
| Dec 2, 2016 | Endure 400 Scrub-Stat (chlorhexidine gluconate) Foam Forming Solution, 4%, pa... | Subpotent Drug | Class III | Ecolab, Inc. |
| Dec 2, 2016 | Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, R... | Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 25... | Class III | Shire PLC |
| Dec 1, 2016 | Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per ... | Failed Dissolution Specifications | Class III | Teva Pharmaceuticals USA |
| Nov 30, 2016 | MegaJex Herbal Supplement, Maximum Formula for Men, Fast acting, Increase Sta... | Marketed without an Approved NDA/ANDA; product contains sildenafil and tadalafil which are active... | Class I | MS Bionic |
| Nov 23, 2016 | Domperidone capsules 10 mg, compounded, dispensed in 60, 90, and 360 count b... | Marketed without an approved NDA/ANDA for which safety and efficacy has not been established. | Class I | Jeffreys Drug Store |
| Nov 22, 2016 | Toms of Maine Naturally Dry Natural Powder Antiperspirant Stick, Distributed... | Labeling: Label Mix Up- Incorrect back label applied to the product. | Class III | Les Emballages Knowlton Inc. |
| Nov 22, 2016 | PROTONIX I.V. (pantoprazole sodium) for Injection, Equivalent to 40 mg pantop... | Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point. | Class III | Pfizer Inc. |
| Nov 18, 2016 | Calcium Chloride 1 g/50 mL* Added to 5% Dextrose (20 mg/mL)*, Single-Dose Bag... | Lack of Assurance of Sterility - the firm is recalling select sterile drug products. | Class II | Cantrell Drug Company |
| Nov 18, 2016 | Morphine Sulfate 1 mg/mL in 0.9% Sodium Chloride, 100 mL Bag, Single-Dose Bag... | Lack of Assurance of Sterility - the firm is recalling select sterile drug products. | Class II | Cantrell Drug Company |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.